Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Articles|May 22, 2023
Daily Dose: Global Deaths from Ischemic Stroke May Reach 5 Million by 2030
Author(s)Sydney Jennings
Advertisement
Patient Care brings primary care clinicians a lot of medical news every day—it’s easy to miss an important study. The Daily Dose provides a concise summary of one of the website's leading stories you may not have seen.
On May 19, 2023, we reported on a study published in Neurology that analyzed the current and predicted global disease burden of ischemic stroke (IS) including identification of populations at high risk as well as attributable risk factors.
The study
Researchers analyzed data from the Global Health Data Exchange from 1990 to 2019, and specifically looked at mortality and disability-adjusted life years of IS among different ages, genders, and risk factors in 204 countries and territories.
The findings
Investigators found that as population grew, the global number of IS deaths increased from 2.04 million in 1990 to 3.29 million in 2019. The stroke rate, however, decreased from 66 strokes per 100 000 persons in 1990 to 44 strokes per 100 000 persons in 2019.
Researchers identified the following 7 risk factors for IS:
Smoking
A diet high in sodium
High systolic blood pressure
Increased low-density lipoprotein cholesterol
Kidney dysfunction
High fasting blood sugar levels
Having a high body mass index
In addition, investigators used the data from the Global Health Data Exchange to predict the number of IS deaths for 2020-2030. They observed that the global number of IS deaths is expected to increase further to 4.90 million by 2030. When authors factored in the 7 risk factors, they estimated that the overall number of IS deaths could reach 6.4 million if the risk factors are not controlled or prevented.
Clinical implications
“Our findings have implications for the allocation of care resources, health care planning, and the development and implementation of primary prevention interventions for stroke that require support from data, primarily including the reduction of metabolic risk factors (eg, blood glucose and weight screening and management) and behavioral risk factors (eg, smoking cessation and improving poor dietary habits). In addition, at the national level, the reduction of poverty and racial and socioeconomic inequalities through appropriate measures, such as legislation and taxation, will be important to reduce cardiovascular disease, as well as other non-communicable diseases."
Click here for more details.
Advertisement
Related to this article
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Advertisement
Advertisement